Case Study | How Intelligent Collaboration Transformed a Generic into a Best-in-Class New Drug

Author: Andrea Franks, Project Manager, Development Services

Oct 2020

A pharmaceutical developer specializing in leveraging common compounds for new indications needed to transform a generic solid active pharmaceutical ingredient (API) into a commercial sterile injectable approved by regulators. Read how collaboration and the drive to find a workable solution led to a successful drug development program.

 

 

You can download the full white paper by completing the form below.

Pfizer CentreOne would like to send you information which we believe may be of value to you and relevant to your work. If you would like to receive such information, please tick the box below.